相似文献
1
Probiotics and the gut microbiota in intestinal health and disease.
Nat Rev Gastroenterol Hepatol. 2010 Sep;7(9):503-14. doi: 10.1038/nrgastro.2010.117. Epub 2010 Jul 27.
2
Prebiotics and probiotics: their role in the management of gastrointestinal disorders in adults.
Nutr Clin Pract. 2012 Apr;27(2):195-200. doi: 10.1177/0884533611423926. Epub 2011 Nov 29.
3
Probiotics in the mechanism of protection against gut inflammation and therapy of gastrointestinal disorders.
Curr Pharm Des. 2014;20(7):1149-55. doi: 10.2174/13816128113199990422.
4
The therapeutic effect of probiotic bacteria on gastrointestinal diseases.
Adv Clin Exp Med. 2013 Sep-Oct;22(5):759-66.
5
Probiotics: an update.
J Pediatr (Rio J). 2015 Jan-Feb;91(1):6-21. doi: 10.1016/j.jped.2014.08.005. Epub 2014 Oct 23.
6
Probiotics and the gastrointestinal tract: where are we in 2005?
World J Gastroenterol. 2006 Feb 14;12(6):853-7. doi: 10.3748/wjg.v12.i6.853.
7
Probiotics as functional food in the treatment of diarrhea.
Curr Opin Clin Nutr Metab Care. 2006 Nov;9(6):717-21. doi: 10.1097/01.mco.0000247477.02650.51.
8
Probiotics in gastrointestinal disorders.
Hosp Pract (1995). 2010 Nov;38(4):122-9. doi: 10.3810/hp.2010.11.349.
9
Pre- and probiotic overview.
Curr Opin Pharmacol. 2018 Dec;43:87-92. doi: 10.1016/j.coph.2018.08.010. Epub 2018 Sep 13.
10
Review article: the use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease.
Aliment Pharmacol Ther. 1998 Sep;12(9):807-22. doi: 10.1046/j.1365-2036.1998.00386.x.
引用本文的文献
1
Improved prebiotic-based "shield" equipped probiotics for enhanced colon cancer therapy by polarizing M1 macrophages and regulating intestinal microbiota.
Acta Pharm Sin B. 2025 Aug;15(8):4225-4247. doi: 10.1016/j.apsb.2025.05.040. Epub 2025 Jun 3.
2
High-dose multi-strain Bacillus probiotics enhance treatment and reduce antibiotic usage in children with persistent diarrhea through immune and microbiota modulation.
Sci Rep. 2025 Aug 18;15(1):30231. doi: 10.1038/s41598-025-15199-y.
3
and Its Postbiotics Ameliorate Ulcerative Colitis Through Gut Microbiota Modulation, Intestinal Barrier Restoration, and HIF1α/AhR-IL-22 Axis Activation: Combined In Vitro and In Vivo Evidence.
Nutrients. 2025 Aug 1;17(15):2537. doi: 10.3390/nu17152537.
4
Mechanisms underlying alterations of the gut microbiota by exercise and their role in shaping ecological resilience.
FEMS Microbiol Rev. 2025 Jan 14;49. doi: 10.1093/femsre/fuaf037.
5
Native Lactobacillus and Bifidobacterium probiotics modulate autophagy genes and exert anti-inflammatory effect.
Sci Rep. 2025 Jul 11;15(1):25006. doi: 10.1038/s41598-025-09596-6.
6
Lead exposure in relation to gut homeostasis, microbiota, and metabolites.
Appl Environ Microbiol. 2025 Jul 23;91(7):e0037225. doi: 10.1128/aem.00372-25. Epub 2025 Jul 3.
7
Effects of short-chain fatty acid-producing probiotic metabolites on symptom relief and intestinal barrier function in patients with irritable bowel syndrome: a double-blind, randomized controlled trial.
Front Cell Infect Microbiol. 2025 Jun 12;15:1616066. doi: 10.3389/fcimb.2025.1616066. eCollection 2025.
8
Compound probiotics promote the growth of piglets through activating the JAK2/STAT5 signaling pathway.
Front Microbiol. 2025 May 13;16:1480077. doi: 10.3389/fmicb.2025.1480077. eCollection 2025.
9
Antibiotic Resistance Gene Expression in Veterinary Probiotics: Two Sides of the Coin.
Vet Sci. 2025 Mar 2;12(3):217. doi: 10.3390/vetsci12030217.
10
The influence of the gut microbiota on B cells in autoimmune diseases.
Mol Med. 2025 Apr 22;31(1):149. doi: 10.1186/s10020-025-01195-5.
本文引用的文献
1
Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis.
Am J Physiol Gastrointest Liver Physiol. 2009 Nov;297(5):G940-9. doi: 10.1152/ajpgi.00141.2009.
2
Systematic review and meta-analysis of Saccharomyces boulardii in adult patients.
World J Gastroenterol. 2010 May 14;16(18):2202-22. doi: 10.3748/wjg.v16.i18.2202.
3
VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study.
J Pediatr Gastroenterol Nutr. 2010 Jul;51(1):24-30. doi: 10.1097/MPG.0b013e3181ca4d95.
4
Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates.
Pediatrics. 2010 May;125(5):921-30. doi: 10.1542/peds.2009-1301. Epub 2010 Apr 19.
5
Redefining the role of intestinal microbes in the pathogenesis of necrotizing enterocolitis.
Pediatrics. 2010 Apr;125(4):777-85. doi: 10.1542/peds.2009-3149. Epub 2010 Mar 22.
6
Incidence of necrotizing enterocolitis in very-low-birth-weight infants related to the use of Lactobacillus GG.
Acta Paediatr. 2010 Aug;99(8):1135-8. doi: 10.1111/j.1651-2227.2010.01795.x. Epub 2010 Mar 8.
7
A human gut microbial gene catalogue established by metagenomic sequencing.
Nature. 2010 Mar 4;464(7285):59-65. doi: 10.1038/nature08821.
8
Bacterial flora in inflammatory bowel disease.
Dig Dis. 2009;27 Suppl 1:99-103. doi: 10.1159/000268128. Epub 2010 Mar 4.
9
Intestinal dysbiosis and reduced immunoglobulin-coated bacteria associated with coeliac disease in children.
BMC Microbiol. 2010 Feb 24;10:63. doi: 10.1186/1471-2180-10-63.
10
Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults.
PLoS One. 2010 Feb 5;5(2):e9085. doi: 10.1371/journal.pone.0009085.
Zotero 插件